E018 Characterising the earliest neurodegenerative changes in HD: multi-modal neuroimaging insights from the Huntington’s disease young adult study (HD-YAS)

<h3>Background</h3> HD-YAS aims to characterise the HD phenotype ~24 years from predicted disease onset in a unique cohort of gene expansion carriers (GECs), evaluated at two time-points ~4.5 years apart. <h3>Aims</h3> To characterise the earliest neurodegenerative changes with multi-modal MRI. <h3>Methods</h3> 154 participants were recruited: 131 at visit 1 (64 GECs, 67 controls) and 23 additional participants at visit 2 (9 GECs, 14 controls). &gt;90% of participants underwent 3T MRI, providing volume/atrophy, diffusion, structural-connectivity, and quantitative-MRI (multi-parameter mapping (MPMs)) metrics. These were assessed cross-sectionally over pre-defined regions-of-interest, using all datapoints and mixed effect regression with random participant effect. Longitudinal direct change analyses used linear regression of a single change measure per participant. <h3>Results</h3> Volumetrics: Cross-sectionally, GECs showed reductions in whole-brain, grey-matter, white-matter, caudate and putamen volumes compared with controls, which were associated with age, CAG, or their interaction (FDR&lt;0.15). Longitudinally, elevated atrophy rates were evident in all regions-of-interest (FDR&lt;0.02), and most prominent in the caudate and putamen (FDR&lt;1.2x10–9); rates were influenced by age, CAG or their interaction (FDR&lt;1.5x10–2). MPMs: Cross-sectionally, R1 was elevated in the putamen in GECs compared with controls (FDR=0.1); and associated with age and CAG (FDR=0.1), suggestive of increased iron levels. There was no evidence of differences in metrics sensitive to demyelination. There were no significant longitudinal findings. Structural connectivity: No significant findings. <h3>Conclusions</h3> Elevated atrophy rates, particularly striatal, are evident &gt;20 years prior to predicted symptom onset. Increased iron in the putamen may be a very early feature. Together with the absence of congruent myelin-contrast decreases, this is suggestive of increased levels of toxicity and neuronal loss.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.114
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

E018 Characterising the earliest neurodegenerative changes in HD: multi-modal neuroimaging insights from the Huntington’s disease young adult study (HD-YAS)

Rachael I. Scahill, Douglas R. Langbehn, Edward J. Wild, Kate Fayer et al.
1 links
Genetic Neurodegenerative Diseases
article

E018 Characterising the earliest neurodegenerative changes in HD: multi-modal neuroimaging insights from the Huntington’s disease young adult study (HD-YAS)

Rachael I. Scahill, Douglas R. Langbehn, Edward J. Wild, Kate Fayer, Michela Leocadi, Sarah J. Tabrizi, Mena S. Farag, Olivia Thackeray, Hui Zhang, Christopher S. Parker, Michael Murphy, Nicola Z. Hobbs
article en

Abstract

<h3>Background</h3> HD-YAS aims to characterise the HD phenotype ~24 years from predicted disease onset in a unique cohort of gene expansion carriers (GECs), evaluated at two time-points ~4.5 years apart. <h3>Aims</h3> To characterise the earliest neurodegenerative changes with multi-modal MRI. <h3>Methods</h3> 154 participants were recruited: 131 at visit 1 (64 GECs, 67 controls) and 23 additional participants at visit 2 (9 GECs, 14 controls). &gt;90% of participants underwent 3T MRI, providing volume/atrophy, diffusion, structural-connectivity, and quantitative-MRI (multi-parameter mapping (MPMs)) metrics. These were assessed cross-sectionally over pre-defined regions-of-interest, using all datapoints and mixed effect regression with random participant effect. Longitudinal direct change analyses used linear regression of a single change measure per participant. <h3>Results</h3> Volumetrics: Cross-sectionally, GECs showed reductions in whole-brain, grey-matter, white-matter, caudate and putamen volumes compared with controls, which were associated with age, CAG, or their interaction (FDR&lt;0.15). Longitudinally, elevated atrophy rates were evident in all regions-of-interest (FDR&lt;0.02), and most prominent in the caudate and putamen (FDR&lt;1.2x10–9); rates were influenced by age, CAG or their interaction (FDR&lt;1.5x10–2). MPMs: Cross-sectionally, R1 was elevated in the putamen in GECs compared with controls (FDR=0.1); and associated with age and CAG (FDR=0.1), suggestive of increased iron levels. There was no evidence of differences in metrics sensitive to demyelination. There were no significant longitudinal findings. Structural connectivity: No significant findings. <h3>Conclusions</h3> Elevated atrophy rates, particularly striatal, are evident &gt;20 years prior to predicted symptom onset. Increased iron in the putamen may be a very early feature. Together with the absence of congruent myelin-contrast decreases, this is suggestive of increased levels of toxicity and neuronal loss.

University of Iowa (US), National Hospital for Neurology and Neurosurgery (GB), University College London (GB)
Openalex Percentile: Top 85%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.